AAME — Stock Film
STOCK FILMSCENE 1/11AAME · $1.29
Stock Expert AI presents
AAME
Atlantic American Corporation
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
Atlantic American Corporation. What it actually does.

Provides life insurance products, including individual and group whole life insurance. Offers Medicare supplement insurance to cover gaps in traditional Medicare. Now — the numbers.

on the stock market since 1980
155 employees
$26.3M market value
Revenue last year:
$188.2M
The loss that same year:
$4.3M
Sales don’t cover the costs; the gap drains from the cash pile every year.

The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.

THE SALES TREND
Sales are moving sideways.

No real growth (-1% a year). Red columns mark years that ended in a loss.

$195.3M
2020
2021
2022
2023
$188.2M
2024
In the vault right now:
$35.6M
DEBT: $37.8M
At this pace, that money lasts about 8.3 years.

At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.

THE PRICE TAG
MARKET VALUE / ANNUAL SALES
0.1×

This company is not turning a profit, so the market is pricing its sales instead: 0.1× for every dollar of annual revenue.

Against companies in its own sector, it looks cheaper than 91% of them.

No analyst target is on record for this company.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
47
weak

Clearly below the class average.

FINANCIAL STRENGTH
52
average

For a bank, strength is measured by capital buffers and reserves — not cash minus debt.

VALUATION
91
very strong

The price looks reasonable next to what the company earns.

GROWTH
8
very weak

Clearly below the class average.

PRICE MOMENTUM
1
very weak

Clearly below the class average.

WORTH WATCHING

Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.

Growth: Sales growth trails the sector average.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 71% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/1
Sales are holding up

The company sells $188.2M a year; the problem isn’t sales — it’s costs running above that number.

1
THE RISKS · 1/3
Small scale, thin loss

A loss of $4.3M against $188.2M in annual sales.

2
THE RISKS · 2/3
The stock has lost its spark

Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 1/100. For a turnaround signal, the stock first needs to close the gap with the market.

3
THE RISKS · 3/3
Growth trails the sector

The growth engine is running at low revs right now. Report-card grade: 8/100.

FINALE · THE GRADE
C
46 / 100 · MoonshotScore

On our five-subject report card, AAME sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: AAME’s sales are going backwards, and it closed last year at a loss. The road back runs through both.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →

Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.

This was a film — not investment advice.
Data: FMP & company filings
Sep 11, 2026 · stockexpertai.com · Stock Film